yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34617892-1E93CE73-BA37-4FB0-B5BD-ECBB3BD0E45E
Q34617892-1E93CE73-BA37-4FB0-B5BD-ECBB3BD0E45E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34617892-1E93CE73-BA37-4FB0-B5BD-ECBB3BD0E45E
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.
P2860
Q34617892-1E93CE73-BA37-4FB0-B5BD-ECBB3BD0E45E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34617892-1E93CE73-BA37-4FB0-B5BD-ECBB3BD0E45E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53b15a3afacc9af3e9ad8b2ad2b9ddf339449bb4
P2860
Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer.